Charles Kellner to Drug Therapy, Combination
This is a "connection" page, showing publications Charles Kellner has written about Drug Therapy, Combination.
Connection Strength
0.488
-
Prolonged succinylcholine action during electroconvulsive therapy (ECT) after cytarabine, vincristine, and rituximab chemotherapy. J ECT. 2011 Mar; 27(1):e42-3.
Score: 0.326
-
Is baseline medication resistance associated with potential for relapse after successful remission of a depressive episode with ECT? Data from the Consortium for Research on Electroconvulsive Therapy (CORE). J Clin Psychiatry. 2009 Feb; 70(2):232-7.
Score: 0.070
-
Effects of continuation electroconvulsive therapy on quality of life in elderly depressed patients: A randomized clinical trial. J Psychiatr Res. 2018 02; 97:65-69.
Score: 0.032
-
Supraventricular tachycardia in a patient receiving ECT, clozapine, and caffeine. Convuls Ther. 1994 Sep; 10(3):228-31.
Score: 0.026
-
A randomized controlled trial comparing the memory effects of continuation electroconvulsive therapy versus continuation pharmacotherapy: results from the Consortium for Research in ECT (CORE) study. J Clin Psychiatry. 2010 Feb; 71(2):185-93.
Score: 0.019
-
Concurrent use of bromocriptine and fluphenazine. J Clin Psychiatry. 1985 Oct; 46(10):455.
Score: 0.014